EphA2-targeted alpha-particle theranostics for enhancing PDAC treatment
Abstract Background: Pancreatic ductal adenocarcinoma (PDAC) presents a formidable challenge in oncology due to its aggressive nature and resistance to…
Abstract Background: Pancreatic ductal adenocarcinoma (PDAC) presents a formidable challenge in oncology due to its aggressive nature and resistance to…
Abstract Background: Identification of patients at high risk of surgical-site infections may allow surgeons to minimize associated morbidity. However, there…